Common Themes from Medical Device Manufacturers

Common Themes
The Date of Application for Medical Device Regulation 2017/745 established several new documents and support services to help manufacturers adjust to the new regulatory environment.
Watch Now

Spotlight

Data-driven healthcare organizations need more than a platform. Connect care, IT, and operations teams to the information they need when they need it most — and create happier, healthier days for all.

OTHER ON-DEMAND WEBINARS

Quality Data: The Key to Enhance Value-based

fiercehealthcare

As the healthcare industry moves toward value-based care, payers are increasingly concerned with clinical outcomes. Health plans are finding that they need to leverage all clinical and administrative data, in addition to claims data, to improve member health and optimize reimbursement within value-based payment models. Harmonizing data across the healthcare continuum presents a significant challenge due to the variety of disconnected data elements that must be connected to get a true 360-degree view of member health. Before healthcare organizations can effectively benefit from the data’s value, the data itself needs to be normalized to achieve semantic interoperability.
Watch Now

Healthcare Simulation in Higher Education

Avispl

The Center for Digital Education (CDE) hosted “Future-Ready Learning: How Technology and Simulation Are Transforming Healthcare Education.” This webinar looked at the ways that healthcare simulation solutions are being applied to give competitive advantage to the colleges, universities and teaching hospitals that adopt them.
Watch Now

Hospital/Physician Engagement: Complying With Stark Law and AKS, Protecting Tax Status, Avoiding Deal Breakers

Strafford

This CLE webinar will provide compliance and valuation guidance to counsel for hospitals and physician groups seeking to maximize their relationship, through varied types of professional services agreements (PSAs) in lieu of traditional employment models. There are shifting considerations and trends in today’s healthcare market, as hospitals and physician groups reevaluate the benefits and risks of different engagement models.
Watch Now

Immunotherapy Advances in Small Cell Lung Cancer

Cancerresearch

Small cell lung cancer (SCLC) is aggressive and often difficult to treat, but many patients may have new hope. On August 17, 2018, the FDA approved the first immunotherapy the checkpoint inhibitor nivolumab (Opdivo, Bristol-Myers Squibb for patients with small cell lung cancer. Since this approval, there has been renewed focus on how to make different immunotherapies work for a disease which typicallly comprises 10-15% of all lung cancer cases. In this webinar for patients and caregivers, Matthew Hellmann, M.D., of Memorial Sloan Kettering Cancer Center discusses the new FDA approval, clinical trials, and potential treatments for patients with small cell lung cancer.
Watch Now